201 related articles for article (PubMed ID: 36758835)
1. Severe allergic dysregulation due to a gain of function mutation in the transcription factor STAT6.
Baris S; Benamar M; Chen Q; Catak MC; Martínez-Blanco M; Wang M; Fong J; Massaad MJ; Sefer AP; Kara A; Babayeva R; Eltan SB; Yucelten AD; Bozkurtlar E; Cinel L; Karakoc-Aydiner E; Zheng Y; Wu H; Ozen A; Schmitz-Abe K; Chatila TA
J Allergy Clin Immunol; 2023 Jul; 152(1):182-194.e7. PubMed ID: 36758835
[TBL] [Abstract][Full Text] [Related]
2. STAT6 gain-of-function variant exacerbates multiple allergic symptoms.
Takeuchi I; Yanagi K; Takada S; Uchiyama T; Igarashi A; Motomura K; Hayashi Y; Nagano N; Matsuoka R; Sugiyama H; Yoshioka T; Saito H; Kawai T; Miyaji Y; Inuzuka Y; Matsubara Y; Ohya Y; Shimizu T; Matsumoto K; Arai K; Nomura I; Kaname T; Morita H
J Allergy Clin Immunol; 2023 May; 151(5):1402-1409.e6. PubMed ID: 36538978
[TBL] [Abstract][Full Text] [Related]
3. Human germline gain-of-function in STAT6: from severe allergic disease to lymphoma and beyond.
;
Trends Immunol; 2024 Feb; 45(2):138-153. PubMed ID: 38238227
[TBL] [Abstract][Full Text] [Related]
4. A germline STAT6 gain-of-function variant is associated with early-onset allergies.
Suratannon N; Ittiwut C; Dik WA; Ittiwut R; Meesilpavikkai K; Israsena N; Ingrungruanglert P; Dalm VASH; van Daele PLA; Sanpavat A; Chaijitraruch N; Schrijver B; Buranapraditkun S; Porntaveetus T; Swagemakers SMA; IJspeert H; Palaga T; Suphapeetiporn K; van der Spek PJ; Hirankarn N; Chatchatee P; Martin van Hagen P; Shotelersuk V
J Allergy Clin Immunol; 2023 Feb; 151(2):565-571.e9. PubMed ID: 36216080
[TBL] [Abstract][Full Text] [Related]
5. Autosomal Dominant STAT6 Gain of Function Causes Severe Atopy Associated with Lymphoma.
Minskaia E; Maimaris J; Jenkins P; Albuquerque AS; Hong Y; Eleftheriou D; Gilmour KC; Grace R; Moreira F; Grimbacher B; ; Morris EC; Burns SO
J Clin Immunol; 2023 Oct; 43(7):1611-1622. PubMed ID: 37316763
[TBL] [Abstract][Full Text] [Related]
6. Human germline heterozygous gain-of-function STAT6 variants cause severe allergic disease.
Sharma M; Leung D; Momenilandi M; Jones LCW; Pacillo L; James AE; Murrell JR; Delafontaine S; Maimaris J; Vaseghi-Shanjani M; Del Bel KL; Lu HY; Chua GT; Di Cesare S; Fornes O; Liu Z; Di Matteo G; Fu MP; Amodio D; Tam IYS; Chan GSW; Sharma AA; Dalmann J; van der Lee R; Blanchard-Rohner G; Lin S; Philippot Q; Richmond PA; Lee JJ; Matthews A; Seear M; Turvey AK; Philips RL; Brown-Whitehorn TF; Gray CJ; Izumi K; Treat JR; Wood KH; Lack J; Khleborodova A; Niemela JE; Yang X; Liang R; Kui L; Wong CSM; Poon GWK; Hoischen A; van der Made CI; Yang J; Chan KW; Rosa Duque JSD; Lee PPW; Ho MHK; Chung BHY; Le HTM; Yang W; Rohani P; Fouladvand A; Rokni-Zadeh H; Changi-Ashtiani M; Miryounesi M; Puel A; Shahrooei M; Finocchi A; Rossi P; Rivalta B; Cifaldi C; Novelli A; Passarelli C; Arasi S; Bullens D; Sauer K; Claeys T; Biggs CM; Morris EC; Rosenzweig SD; O'Shea JJ; Wasserman WW; Bedford HM; van Karnebeek CDM; Palma P; Burns SO; Meyts I; Casanova JL; Lyons JJ; Parvaneh N; Nguyen ATV; Cancrini C; Heimall J; Ahmed H; McKinnon ML; Lau YL; Béziat V; Turvey SE
J Exp Med; 2023 May; 220(5):. PubMed ID: 36884218
[TBL] [Abstract][Full Text] [Related]
7. STAT6 joins the gain-of-function club.
Chen K; Ochs HD; Allenspach EJ
J Allergy Clin Immunol; 2023 Jul; 152(1):53-55. PubMed ID: 37192684
[No Abstract] [Full Text] [Related]
8. Piperine Ameliorates Trimellitic Anhydride-Induced Atopic Dermatitis-Like Symptoms by Suppressing Th2-Mediated Immune Responses via Inhibition of STAT6 Phosphorylation.
Choi DW; Jung SY; Shon DH; Shin HS
Molecules; 2020 May; 25(9):. PubMed ID: 32392825
[TBL] [Abstract][Full Text] [Related]
9. Germline STAT6 gain-of-function variants cause severe allergy.
Yamashita M; Morio T
J Allergy Clin Immunol; 2023 May; 151(5):1252-1254. PubMed ID: 36958638
[No Abstract] [Full Text] [Related]
10. Learning while treating: Gain-of-function STAT6 variants in severe allergic disease.
Smith TD; Doherty TA
Cell Rep Med; 2023 May; 4(5):101040. PubMed ID: 37196636
[TBL] [Abstract][Full Text] [Related]
11. Allergic dysregulation and hyperimmunoglobulinemia E in Foxp3 mutant mice.
Lin W; Truong N; Grossman WJ; Haribhai D; Williams CB; Wang J; Martín MG; Chatila TA
J Allergy Clin Immunol; 2005 Nov; 116(5):1106-15. PubMed ID: 16275384
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin I2 Suppresses Proinflammatory Chemokine Expression, CD4 T Cell Activation, and STAT6-Independent Allergic Lung Inflammation.
Zhou W; Zhang J; Goleniewska K; Dulek DE; Toki S; Newcomb DC; Cephus JY; Collins RD; Wu P; Boothby MR; Peebles RS
J Immunol; 2016 Sep; 197(5):1577-86. PubMed ID: 27456482
[TBL] [Abstract][Full Text] [Related]
13. Ruxolitinib reverses dysregulated T helper cell responses and controls autoimmunity caused by a novel signal transducer and activator of transcription 1 (STAT1) gain-of-function mutation.
Weinacht KG; Charbonnier LM; Alroqi F; Plant A; Qiao Q; Wu H; Ma C; Torgerson TR; Rosenzweig SD; Fleisher TA; Notarangelo LD; Hanson IC; Forbes LR; Chatila TA
J Allergy Clin Immunol; 2017 May; 139(5):1629-1640.e2. PubMed ID: 28139313
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-4 up-regulation of epidermal interleukin-19 expression in keratinocytes involves the binding of signal transducer and activator of transcription 6 (Stat6) to the imperfect Stat6 sites.
Bao L; Alexander JB; Shi VY; Mohan GC; Chan LS
Immunology; 2014 Dec; 143(4):601-8. PubMed ID: 24943510
[TBL] [Abstract][Full Text] [Related]
15. Human JAK1 gain of function causes dysregulated myelopoeisis and severe allergic inflammation.
Biggs CM; Cordeiro-Santanach A; Prykhozhij SV; Deveau AP; Lin Y; Del Bel KL; Orben F; Ragotte RJ; Saferali A; Mostafavi S; Dinh L; Dai D; Weinacht KG; Dobbs K; Ott de Bruin L; Sharma M; Tsai K; Priatel JJ; Schreiber RA; Rozmus J; Hosking MC; Shopsowitz KE; McKinnon ML; Vercauteren S; Seear M; Notarangelo LD; Lynn FC; Berman JN; Turvey SE
JCI Insight; 2022 Dec; 7(24):. PubMed ID: 36546480
[TBL] [Abstract][Full Text] [Related]
16. STAT6 polymorphisms are associated with neonatal regulatory T cells and cytokines and atopic diseases at 3 years.
Casaca VI; Illi S; Klucker E; Ballenberger N; Schedel M; von Mutius E; Kabesch M; Schaub B
Allergy; 2013 Oct; 68(10):1249-58. PubMed ID: 24053457
[TBL] [Abstract][Full Text] [Related]
17. JAK-STAT6 Pathway Inhibitors Block Eotaxin-3 Secretion by Epithelial Cells and Fibroblasts from Esophageal Eosinophilia Patients: Promising Agents to Improve Inflammation and Prevent Fibrosis in EoE.
Cheng E; Zhang X; Wilson KS; Wang DH; Park JY; Huo X; Yu C; Zhang Q; Spechler SJ; Souza RF
PLoS One; 2016; 11(6):e0157376. PubMed ID: 27310888
[TBL] [Abstract][Full Text] [Related]
18. YM-341619 suppresses the differentiation of spleen T cells into Th2 cells in vitro, eosinophilia, and airway hyperresponsiveness in rat allergic models.
Ohga K; Kuromitsu S; Takezawa R; Numazaki M; Ishikawa J; Nagashima S; Shimizu Y
Eur J Pharmacol; 2008 Aug; 590(1-3):409-16. PubMed ID: 18590722
[TBL] [Abstract][Full Text] [Related]
19. STAT6-mediated keratitis and blepharitis: a novel murine model of ocular atopic dermatitis.
Turner MJ; DaSilva-Arnold S; Luo N; Hu X; West CC; Sun L; Hill C; Bradish J; Kaplan MH; Travers JB; Sun Y
Invest Ophthalmol Vis Sci; 2014 May; 55(6):3803-8. PubMed ID: 24845637
[TBL] [Abstract][Full Text] [Related]
20. Gene Polymorphism of Interleukin-4, Interleukin-4 Receptor and STAT6 in Children with Atopic Dermatitis in Taif, Saudi Arabia.
Hussein YM; Alzahrani SS; Alharthi AA; Alhazmi AS; Ghonaim MM; Alghamdy AA; El Askary A
Immunol Invest; 2016; 45(3):223-34. PubMed ID: 27018548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
